Paragon Capital Management (Utah)’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-4,944
| Closed | -$1.65M | – | 68 |
|
|
2024
Q3 | $1.65M | Buy |
4,944
+151
| +3% | +$50.5K | 1.22% | 30 |
|
|
2024
Q2 | $1.31M | Buy |
+4,793
| New | +$1.31M | 1% | 47 |
|
|
2024
Q1 | – | Sell |
-4,259
| Closed | -$1.38M | – | 71 |
|
|
2023
Q4 | $1.38M | Buy |
4,259
+1,147
| +37% | +$370K | 1.1% | 37 |
|
|
2023
Q3 | $1.12M | Buy |
3,112
+191
| +7% | +$68.5K | 0.95% | 45 |
|
|
2023
Q2 | $1.11M | Buy |
2,921
+153
| +6% | +$58K | 0.93% | 47 |
|
|
2023
Q1 | $1.33M | Sell |
2,768
-263
| -9% | -$126K | 1.16% | 28 |
|
|
2022
Q4 | $1.27M | Buy |
3,031
+699
| +30% | +$294K | 1.19% | 20 |
|
|
2022
Q3 | $973K | Buy |
2,332
+25
| +1% | +$10.4K | 0.95% | 37 |
|
|
2022
Q2 | $1.14M | Buy |
+2,307
| New | +$1.14M | 1.16% | 24 |
|
|
2022
Q1 | – | Sell |
-1,930
| Closed | -$1.46M | – | 71 |
|
|
2021
Q4 | $1.46M | Buy |
+1,930
| New | +$1.46M | 1.25% | 30 |
|